Enteropathogenic Escherichia coli Uses NleA to Inhibit NLRP3 Inflammasome Activation

PLoS Pathogens

Volumn 11, Issue 9, 2015, Pages 1-23

  Yen, Hilo ^a   Sugimoto, Nakaba ^a   Tobe, Toru ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPYRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; CARRIER PROTEIN; ESCHERICHIA COLI PROTEIN; HYBRID PROTEIN; IL1B PROTEIN, HUMAN; NLEA PROTEIN, E COLI; NLRP3 PROTEIN, HUMAN; PEPTIDE FRAGMENT; PHOTOPROTEIN; RECOMBINANT PROTEIN; VIRULENCE FACTOR;

ARTICLE; BINDING ASSAY; CELL DIFFERENTIATION; CONFOCAL MICROSCOPY; ENTEROPATHOGENIC ESCHERICHIA COLI INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DELETION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; UBIQUITINATION; ANTAGONISTS AND INHIBITORS; CELL LINE; CHEMISTRY; ENTEROPATHOGENIC ESCHERICHIA COLI; ENZYME ACTIVATION; ESCHERICHIA COLI INFECTION; GENETICS; HELA CELL LINE; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INNATE IMMUNITY; KINETICS; MACROPHAGE; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; SECRETION (PROCESS);

CARRIER PROTEINS; CASPASE 1; CELL LINE; ENTEROPATHOGENIC ESCHERICHIA COLI; ENZYME ACTIVATION; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; GENE DELETION; HELA CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INFLAMMASOMES; INTERLEUKIN-1BETA; KINETICS; LUMINESCENT PROTEINS; MACROPHAGES; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; PEPTIDE FRAGMENTS; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; UBIQUITINATION; VIRULENCE FACTORS;

EID: 84943523865     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005121     Document Type: Article

References (49)

1. Clarke SC, (2001) Diarrhoeagenic Escherichia coli—an emerging problem? Diagnos Microbiol Infect Disease 41: 93–98.
2. Kaper JB, Nataro JP, Mobley HL, (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2: 123–140. 15040260
3. Moon HW, Whipp SC, Argenzio RA, Levine MM, Giannella RA, (1983) Attaching and Effacing Activities of Rabbit and Human Enteropathogenic Escherichia coli in Pig and Rabbit Intestines. Infect Immun 41: 1340–1351. 6350186
4. Jerse AE, Yu J, Tall BD, Kaper JB, (1990) A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad of Sci USA 87: 7839–7843.
5. Knutton S, Baldwin T, Williams PH, McNeish AS, (1989) Actin Accumulation at Sites of Bacterial Adhesion to Tissue Culture Cells: Basis of a New Diagnostic Test for Enteropathogenic and Enterohemorrhagic Escherichia coli. Infect Immun 57: 1290–1298. 2647635
6. Garmendia J, Frankel G, Crepin VF, (2005) Enteropathogenic and Enterohemorrhagic Escherichia coli Infections: Translocation, Translocation, Translocation. Infect Immun 73: 2573–2585. 15845459
7. Tobe T, Beatson SA, Taniguchi H, Abe H, Bailey CM, et al. (2006) An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination. Proc Natl Acad Sci U S A 103: 14941–14946. 16990433
8. Iguchi A, Thomson NR, Ogura Y, Saunders D, Ooka T, et al. (2009) Complete genome sequence and comparative genome analysis of enteropathogenic Escherichia coli O127:H6 strain E2348/69. J Bacteriol 191: 347–354. doi: 10.1128/JB.01238-08 18952797
9. Dean P, Kenny B, (2009) The effector repertoire of enteropathogenic E. coli: ganging up on the host cell. Current Opinion in Microbiology 12: 101–109. doi: 10.1016/j.mib.2008.11.006 19144561
10. Johannessen M, Askarian F, Sangvik M, Sollid JE, (2013) Bacterial interference with canonical NFkappaB signalling. Microbiology 159: 2001–2013. doi: 10.1099/mic.0.069369-0 23873783
11. Akira S, Takeda K, (2004) Toll-like receptor signalling. Nat Rev Immunol 4: 499–511. 15229469
12. Wen H, Miao EA, Ting JP, (2013) Mechanisms of NOD-like receptor-associated inflammasome activation. Immunity 39: 432–441. doi: 10.1016/j.immuni.2013.08.037 24054327
13. Tschopp J, Schroder K, (2010) NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production? Nat Rev Immunol 10: 210–215. doi: 10.1038/nri2725 20168318
14. Leemans JC, Cassel SL, Sutterwala FS, (2011) Sensing damage by the NLRP3 inflammasome. Immunological Reviews 243: 152–162. doi: 10.1111/j.1600-065X.2011.01043.x 21884174
15. Vladimer GI, Marty-Roix R, Ghosh S, Weng D, Lien E, (2013) Inflammasomes and host defenses against bacterial infections. Curr Opin Microbiol 16: 23–31. doi: 10.1016/j.mib.2012.11.008 23318142
16. Sander LE, Davis MJ, Boekschoten MV, Amsen D, Dascher CC, et al. (2011) Detection of prokaryotic mRNA signifies microbial viability and promotes immunity. Nature 474: 385–389. doi: 10.1038/nature10072 21602824
17. Kayagaki N, Warming S, Lamkanfi M, Vande Walle L, Louie S, et al. (2011) Non-canonical inflammasome activation targets caspase-11. Nature 479: 117–121. doi: 10.1038/nature10558 22002608
18. Rathinam VA, Vanaja SK, Waggoner L, Sokolovska A, Becker C, et al. (2012) TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria. Cell 150: 606–619. doi: 10.1016/j.cell.2012.07.007 22819539
19. Liu Z, Zaki MH, Vogel P, Gurung P, Finlay BB, et al. (2012) Role of inflammasomes in host defense against Citrobacter rodentium infection. J Biol Chem 287: 16955–16964. doi: 10.1074/jbc.M112.358705 22461621
20. Yang J, Zhao Y, Shi J, Shao F, (2013) Human NAIP and mouse NAIP1 recognize bacterial type III secretion needle protein for inflammasome activation. Proc Natl Acad Sci U S A 110: 14408–14413. doi: 10.1073/pnas.1306376110 23940371
21. Yen H, Ooka T, Iguchi A, Hayashi T, Sugimoto N, et al. (2010) NleC, a Type III Secretion Protease, Compromises NF-kB Activation by Targeting p65/RelA. PLoS Pathog 6: e1001231. doi: 10.1371/journal.ppat.1001231 21187904
22. Latz E, Xiao TS, Stutz A, (2013) Activation and regulation of the inflammasomes. Nat Rev Immunol 13: 397–411. doi: 10.1038/nri3452 23702978
23. Vossenkamper A, Marches O, Fairclough PD, Warnes G, Stagg AJ, et al. (2010) Inhibition of NF-kappaB signaling in human dendritic cells by the enteropathogenic Escherichia coli effector protein NleE. J Immunol 185: 4118–4127. doi: 10.4049/jimmunol.1000500 20833837
24. Newton HJ, Pearson JS, Badea L, Kelly M, Lucas M, et al. (2010) The Type III Effectors NleE and NleB from Enteropathogenic E. coli and OspZ from Shigella Block Nuclear Translocation of NF-kappaB p65. PLoS Pathog 6: e1000898. doi: 10.1371/journal.ppat.1000898 20485572
25. Nadler C, Baruch K, Kobi S, Mills E, Haviv G, et al. (2010) The type III secretion effector NleE inhibits NF-kappaB activation. PLoS Pathog 6: e1000743. doi: 10.1371/journal.ppat.1000743 20126447
26. Zhang L, Ding X, Cui J, Xu H, Chen J, et al. (2012) Cysteine methylation disrupts ubiquitin-chain sensing in NF-[kgr]B activation. Nature 481: 204–208.
27. Sen R, Baltimore D, (1986) Inducibility of k Immunoglobulin enhancer-binding protein NF-kB by posttranslational mechanism. Cell 47: 921–928. 3096580
28. Kostura MJ, Tocci MJ, Limjuco G, Chin J, Cameron P, et al. (1989) Identification of a monocyte specific pre-interleukin 1b convertase activity. Proc Natl Acad of Sci USA 86: 5227–5231.
29. Elliott JM, Rouge L, Wiesmann C, Scheer JM, (2009) Crystal structure of procaspase-1 zymogen domain reveals insight into inflammatory caspase autoactivation. J Biol Chem 284: 6546–6553. doi: 10.1074/jbc.M806121200 19117953
30. Schroder K, Tschopp J, (2010) The inflammasomes. Cell 140: 821–832. doi: 10.1016/j.cell.2010.01.040 20303873
31. Fink SL, Cookson BT, (2006) Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages. Cell Microbiol 8: 1812–1825. 16824040
32. Fernandes-Alnemri T, Wu J, Yu JW, Datta P, Miller B, et al. (2007) The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ 14: 1590–1604. 17599095
33. Juliana C, Fernandes-Alnemri T, Kang S, Farias A, Qin F, et al. (2012) Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation. J Biol Chem 287: 36617–36622. doi: 10.1074/jbc.M112.407130 22948162
34. Py BF, Kim MS, Vakifahmetoglu-Norberg H, Yuan J, (2013) Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity. Mol Cell 49: 331–338. doi: 10.1016/j.molcel.2012.11.009 23246432
35. Poyet JL, Srinivasula SM, Tnani M, Razmara M, Fernandes-Alnemri T, et al. (2001) Identification of Ipaf, a human caspase-1-activating protein related to Apaf-1. J Biol Chem 276: 28309–28313. 11390368
36. Nordlander S, Pott J, Maloy KJ, (2013) NLRC4 expression in intestinal epithelial cells mediates protection against an enteric pathogen. Mucosal Immunol.
37. Zhao Y, Yang J, Shi J, Gong Y-N, Lu Q, et al. (2011) The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature\ 477\: 596\–600\. doi: 10.1038/nature10510 21918512
38. Brodsky IE, Palm NW, Sadanand S, Ryndak MB, Sutterwala FS, et al. (2010) A Yersinia Effector Protein Promotes Virulence by Preventing Inflammasome Recognition of the Type III Secretion System. Cel Host Microb 7: 376–387.
39. LaRock CN, Cookson BT, (2012) The Yersinia Virulence Effector YopM Binds Caspase-1 to Arrest Inflammasome Assembly and Processing. Cell Host & Microbe 12: 799–805.
40. Kobayashi T, Ogawa M, Sanada T, Mimuro H, Kim M, et al. (2013) The Shigella OspC3 effector inhibits caspase-4, antagonizes inflammatory cell death, and promotes epithelial infection. Cell Host Microbe 13: 570–583. doi: 10.1016/j.chom.2013.04.012 23684308
41. Gregory SM, Davis BK, West JA, Taxman DJ, Matsuzawa S, et al. (2011) Discovery of a viral NLR homolog that inhibits the inflammasome. Science 331: 330–334. doi: 10.1126/science.1199478 21252346
42. Komune N, Ichinohe T, Ito M, Yanagi Y, (2011) Measles virus V protein inhibits NLRP3 inflammasome-mediated interleukin-1beta secretion. J Virol 85: 13019–13026. doi: 10.1128/JVI.05942-11 21994456
43. Kim J, Thanabalasuriar A, Chaworth-Musters T, Fromme JC, Frey EA, et al. (2007) The Bacterial Virulence Factor NleA Inhibits Cellular Protein Secretion by Disrupting Mammalian COPII Function. Cell Host & Microbe 2: 160–171.
44. Thanabalasuriar A, Bergeron J, Gillingham A, Mimee M, Thomassin JL, et al. (2012) Sec24 interaction is essential for localization and virulence-associated function of the bacterial effector protein NleA. Cell Microbiol 14: 1206–1218. doi: 10.1111/j.1462-5822.2012.01789.x 22432415
45. Lee SF, Kelly M, McAlister A, Luck SN, Garcia EL, et al. (2008) A C-terminal class I PDZ binding motif of EspI/NleA modulates the virulence of attaching and effacing Escherichia coli and Citrobacter rodentium. Cell Microbiol 10: 499–513. 17979986
46. Gruenheid S, Sekirov I, Thomas NA, Deng W, O'Donnell P, et al. (2004) Identification and characterization of NleA, a non-LEE-encoded type III translocated virulence factor of enterohaemorrhagic Escherichia coli O157:H7. Mol Microbiol 51: 1233–1249. 14982621
47. Song-Zhao GX, Srinivasan N, Pott J, Baban D, Frankel G, et al. (2014) Nlrp3 activation in the intestinal epithelium protects against a mucosal pathogen. Mucosal Immunol 7: 763–774. doi: 10.1038/mi.2013.94 24280937
48. Wlodarska M, Thaiss Christoph A, Nowarski R, Henao-Mejia J, Zhang J-P, et al. (2014) NLRP6 Inflammasome Orchestrates the Colonic Host-Microbial Interface by Regulating Goblet Cell Mucus Secretion. Cell 156: 1045–1059. doi: 10.1016/j.cell.2014.01.026 24581500
49. Datsenko KA, Wanner BL, (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97: 6640–6645. 10829079